Announcements
Sidley Represents Valius Sciences in Financing Raising More Than US$10 Million for Future Cancer Diagnostics
April 23, 2026
Sidley represented Valius Sciences, a San Francisco-based healthcare diagnostics company focused on cancer treatment, in a Series Seed financing round that raised more than US$10 million. The round was led by 8VC and Basis Set Ventures.
More information about the transaction can be found here.
The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital) and included Daniel Wei (Emerging Companies and Venture Capital) and Laura DeMassa (M&A).
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Restive Ventures in Formation of US$45 Million Restive Fund IIIMay 29, 2026Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026Sidley Represents Peach Finance in Its Acquisition by SoFiMay 26, 20262026 Emerging Companies & Venture Capital SummitWednesday, May 20, 2026Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026International Emergency Economic Powers Act Tariff Refund Claims: Key Considerations for Lenders, Borrowers, and Claims PurchasersApril 30, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory